Reversal of neuromuscular block: optimum dosage of neostigmine. 1986

D Goldhill

UI MeSH Term Description Entries
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D009407 Nerve Block Interruption of NEURAL CONDUCTION in peripheral nerves or nerve trunks by the injection of a local anesthetic agent (e.g., LIDOCAINE; PHENOL; BOTULINUM TOXINS) to manage or treat pain. Chemical Neurolysis,Chemodenervation,Nerve Blockade,Block, Nerve,Blockade, Nerve,Blockades, Nerve,Blocks, Nerve,Chemical Neurolyses,Chemodenervations,Nerve Blockades,Nerve Blocks,Neurolyses, Chemical,Neurolysis, Chemical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Goldhill
February 1980, Middle East journal of anaesthesiology,
D Goldhill
September 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
D Goldhill
February 2001, Middle East journal of anaesthesiology,
D Goldhill
June 2016, Middle East journal of anaesthesiology,
D Goldhill
May 2014, The Cochrane database of systematic reviews,
D Goldhill
January 1990, Research in veterinary science,
D Goldhill
October 2005, Acta anaesthesiologica Scandinavica,
Copied contents to your clipboard!